4
Changes in Ownership
Arbutus Biopharma Corp Filed Acc 0001447028-22-000009
Options or other derivatives
- Chief Scientific Officer acquired 285,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Sofia Michael J. · Chief Scientific Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-01-20 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +285,000 | $2.81 | $800,850 | 285,000 | D |
Loading xslF345X03/wf-form4_164271925075900.xml…